Back to glossary
Biomarkers

Neutrophil-lymphocyte ratio (NLR)

DENeutrophilen-Lymphozyten-Quotient (NLR)

Reviewed by

The neutrophil-lymphocyte ratio (NLR) is derived from a standard complete blood count as the absolute neutrophil count divided by the absolute lymphocyte count, with a typical reference range of approximately 0.78–3.53 in healthy adults (Forget 2017). It reflects the balance between the innate (neutrophil-driven) and adaptive (lymphocyte-driven) arms of the immune system: higher NLR indicates relative dominance of innate proinflammatory activity and/or suppression of adaptive immunity. Elevated NLR is associated with worse prognosis in a broad range of cancers, higher incidence of cardiovascular events, chronic kidney disease, and metabolic syndrome, and independently predicts all-cause mortality in large population cohorts. Physiologically, NLR rises sharply during acute stress, infection, or corticosteroid use, but persistently elevated values at rest are a marker of chronic inflammaging and immune senescence, making it a useful, cost-free index derived from routine laboratory data.

Sources

  1. Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. (2017). What is the normal value of the neutrophil-to-lymphocyte ratio?. *BMC Research Notes*doi:10.1186/s13104-016-2335-5
  2. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al.. (2014). Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. *Journal of the National Cancer Institute*doi:10.1093/jnci/dju124